Bionano Genomics, Inc. (BNGO) Total liabilities 2017–2025
Bionano Genomics, Inc. (BNGO) total liabilities at each fiscal year-end, per SEC filings.
$29.2MFY2025 · since FY2017: $17.4M → $29.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.2M | -29.4% |
| FY2024 | $41.3M | -65.1% |
| FY2023 | $118.2M | +103.5% |
| FY2022 | $58.1M | +45.3% |
| FY2021 | $40.0M | +57.6% |
| FY2020 | $25.4M | -4.6% |
| FY2019 | $26.6M | +81.3% |
| FY2018 | $14.7M | -15.5% |
| FY2017 | $17.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating marginBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Shareholders’ equityBNGO overview →